Bekanntmachung • Apr 27
Stem, Inc., Annual General Meeting, Jun 03, 2026 Stem, Inc., Annual General Meeting, Jun 03, 2026. Buy Or Sell Opportunity • Apr 22
Now 25% overvalued Over the last 90 days, the stock has fallen 38% to US$11.80. The fair value is estimated to be US$9.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 37% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are forecast to decline by 105% per annum over the same time period. Bekanntmachung • Apr 14
Stem, Inc. to Report Q1, 2026 Results on May 06, 2026 Stem, Inc. announced that they will report Q1, 2026 results at 4:05 PM, Eastern Standard Time on May 06, 2026 Bekanntmachung • Mar 07
Stem, Inc. has filed a Follow-on Equity Offering in the amount of $30 million. Stem, Inc. has filed a Follow-on Equity Offering in the amount of $30 million.
Security Name: Common Stock
Security Type: Common Stock
Transaction Features: At the Market Offering Price Target Changed • Mar 06
Price target decreased by 9.6% to US$17.33 Down from US$19.17, the current price target is an average from 6 analysts. New target price is 43% above last closing price of US$12.11. Stock is up 37% over the past year. The company is forecast to post a net loss per share of US$7.58 compared to earnings per share of US$16.52 last year. New Risk • Mar 06
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 121% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.9% operating cash flow to total debt). Negative equity (-US$249m). Earnings are forecast to decline by an average of 121% per year for the foreseeable future. High level of non-cash earnings (146% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (US$84.3m market cap). Reported Earnings • Mar 06
Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2025 results: EPS: US$16.52 (up from US$106 loss in FY 2024). Revenue: US$156.3m (up 8.1% from FY 2024). Net income: US$137.8m (up US$991.8m from FY 2024). Profit margin: 88% (up from net loss in FY 2024). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) missed analyst estimates significantly. Revenue is forecast to grow 9.2% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in the US. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings. Bekanntmachung • Mar 05
Stem, Inc. Provides Revenue Guidance for the Full-Year Ended December 31, 2026 Stem, Inc. provided revenue guidance for the full-year ended December 31, 2026. For the year, company expects Revenue of $140 million to $190 million. New Risk • Feb 11
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$99.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-US$235m). Earnings are forecast to decline by an average of 100% per year for the foreseeable future. High level of non-cash earnings (104% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Significant insider selling over the past 3 months (US$60k sold). Market cap is less than US$100m (US$99.3m market cap). Bekanntmachung • Feb 10
Stem, Inc. to Report Q4, 2025 Results on Mar 04, 2026 Stem, Inc. announced that they will report Q4, 2025 results at 4:05 PM, US Eastern Standard Time on Mar 04, 2026 Bekanntmachung • Dec 20
Stem, Inc. Receives Court Order Dismissing All Claims in Securities Class Action with Prejudice On December 17, 2025, the United States District Court for the Northern District of California entered an order dismissing with prejudice all claims in the putative securities class action pending against Stem, Inc. and certain of its former officers, directors and employees. The lawsuit made various claims under the federal securities laws and was captioned In re Stem, Inc. Sec. Litig., Case No. 23-CV-02329-MMC. Bekanntmachung • Dec 03
Stem, Inc. Appoints Arun Narayanan to the Board as A Class I Director, Effective from on December 1, 2025 Stem, Inc. appointed Arun Narayanan, Chief Executive Officer of the Company, to the Board as a Class I Director, effective On December 1, 2025, to fill the vacancy created by such increase. Mr. Narayanan will receive no compensation for his service as a director of the Board. Recent Insider Transactions • Nov 20
Chief Accounting Officer recently sold US$60k worth of stock On the 18th of November, Rahul Shukla sold around 4k shares on-market at roughly US$16.21 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Oct 31
Third quarter 2025 earnings: EPS misses analyst expectations Third quarter 2025 results: US$2.84 loss per share (improved from US$18.24 loss in 3Q 2024). Revenue: US$38.2m (up 31% from 3Q 2024). Net loss: US$23.8m (loss narrowed 84% from 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electrical industry in the US. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings. Bekanntmachung • Oct 30
Stem, Inc. Revises Earnings Guidance for the Full Year 2025 Stem, Inc. revised earnings guidance for the full year 2025. For the year, the company now expects revenue in the range of $135 million to $160 million compared to previous guidance of $125 million to $175million. Bekanntmachung • Oct 07
Stem, Inc. to Report Q3, 2025 Results on Oct 29, 2025 Stem, Inc. announced that they will report Q3, 2025 results at 4:05 PM, US Eastern Standard Time on Oct 29, 2025 Buy Or Sell Opportunity • Sep 11
Now 33% overvalued after recent price rise Over the last 90 days, the stock has risen 61% to US$14.60. The fair value is estimated to be US$11.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 24% in 2 years. Earnings are forecast to decline by 139% in the next 2 years. Bekanntmachung • Sep 03
Stem, Inc. Launches PowerTrack™? EMS, Expanding Global Product Suite for Standalone and Hybrid Energy Storage Control Stem, Inc. announced its further strategic expansion into the standalone storage and solar-plus-storage control market with the launch of PowerTrack™? Energy Management System (EMS). Operators, however, face significant challenges in controlling these complex assets, managing competing revenue streams between solar and storage, and navigating increasingly sophisticated grid requirements that demand seamless integration between renewable generation and energy storage capabilities. PowerTrack EMS in intended to tackle these challenges through a complete technical stack that combines onsite hardware with industry-leading, configurable cloud software to deliver real-time monitoring, advanced control capabilities across entire energy portfolios without black-box limitations that restrict future flexibility. A differentiation in the market, PowerTrack EMS users will always retain full ownership of their EMS infrastructure without mandatory subscriptions or vendor lock-in that could restrict operational flexibility. Key Capabilities: Unified hybrid control to manage solar generation and battery storage as one integrated system, enabling maximum revenue capture and enhanced performance; 32% reduction in engineering hours through pre-configuration, AI-enabled tuning and remote commissioning capabilities; 99.99% controller reliability ensuring consistent revenue streams and eliminating downtime; Sophisticated control modes enabling participation in diverse grid services markets, with further control modes in development; Advanced "value stacking" capabilities to maximize revenue across multiple applications; Future-proof architecture supporting seamless asset expansion or hybridization with transparent, flexible software providing full system visibility and preventing vendor dependencies that limit scaling flexibility. The solution will serve utility-scale and C&I projects for international developers, EPCs, integrators, and existing PowerTrack customers seeking storage integration or hybrid optimization. Price Target Changed • Aug 23
Price target increased by 10% to US$13.17 Up from US$11.93, the current price target is an average from 6 analysts. New target price is 21% below last closing price of US$16.74. Stock is up 12% over the past year. The company is forecast to post earnings per share of US$6.28 next year compared to a net loss per share of US$106 last year. Breakeven Date Change • Aug 11
Forecast to breakeven in 2025 The 5 analysts covering Stem expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$147.1m in 2025. Reported Earnings • Aug 10
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Second quarter 2025 results: EPS: US$24.31 (up from US$71.82 loss in 2Q 2024). Revenue: US$38.4m (up 13% from 2Q 2024). Net income: US$202.5m (up US$784.8m from 2Q 2024). Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Electrical industry in the US. Bekanntmachung • Aug 08
Stem, Inc. Reaffirms Earnings Guidance for the Year 2025 Stem, Inc. reaffirmed earnings guidance for the year 2025. For the year, the company expects revenue to be in the range of $125 million to $175 million. Bekanntmachung • Jul 09
Stem, Inc. to Report Q2, 2025 Results on Aug 07, 2025 Stem, Inc. announced that they will report Q2, 2025 results at 4:05 PM, US Eastern Standard Time on Aug 07, 2025 Bekanntmachung • Apr 30
Stem, Inc. Reaffirms Earnings Guidance for the Year 2025 Stem, Inc. reaffirmed earnings guidance for the year 2025. For the year, the company expects revenue to be in the range of $125 million to $175 million. Bekanntmachung • Apr 16
Stem, Inc. Announces Reduction in Force Plan Stem, Inc. announced on April 9, 2025, a reduction in force plan (the “Plan”), as part of the Company’s broader efforts to prioritize investments in software, reduce operating costs, increase efficiency, drive profitable growth and increase stockholder value. The Plan will reduce the Company’s global full-time workforce by approximately 27%. The Company estimates the total cash expenditures associated with the Plan to be approximately $6.0 million to $6.5 million, primarily consisting of severance payments, notice period payments in applicable jurisdictions, employee benefits and related costs. The Company expects to incur these expenses primarily in the second quarter of 2025. As a result of the Plan, the Company estimates partial year 2025 savings to be approximately $24 million and full-year 2026 savings to be approximately $30 million. These savings exclude an expected one-time GAAP pre-tax charge in the second quarter 2025 in the range of $6.0 million to $6.5 million, substantially all of which is expected to be related to severance payments and post-employment benefits, which the Company expects to treat as an adjustment item for purposes of reporting adjusted EBITDA. The estimates of the charges and expenditures that the Company expects to incur in connection with the Plan, and the timing thereof, as well as the related estimated savings, are subject to a number of assumptions, including local law requirements in various jurisdictions, and actual amounts may differ materially from estimates. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Plan. The actions associated with the Plan are expected to be substantially complete by the end of the second quarter of 2025. Price Target Changed • Apr 14
Price target decreased by 8.5% to US$0.98 Down from US$1.07, the current price target is an average from 11 analysts. New target price is 191% above last closing price of US$0.34. Stock is down 79% over the past year. The company is forecast to post a net loss per share of US$0.62 next year compared to a net loss per share of US$5.29 last year. Bekanntmachung • Apr 11
Stem, Inc., Annual General Meeting, Jun 04, 2025 Stem, Inc., Annual General Meeting, Jun 04, 2025. Bekanntmachung • Mar 18
Stem, Inc. Appoints Krishna Shivram to the Board as A Class I Director and Vasudevan (Vasu) Guruswamy to the Board as A Class III Director Stem, Inc. announced that its Board of Directors has appointed Mr. Krishna Shivram to the Board as a Class I director and Mr. Vasudevan (Vasu) Guruswamy to the Board as a Class III director, both effective March 17, 2025. Mr. Shivram is an experienced leader of global public companies with expertise in corporate finance, capital structure management, and mergers and acquisitions. He is Managing Partner at Veritec Capital Partners and General Partner at Lavni Ventures India and USA. Mr. Shivram has a Bachelor of Commerce degree from Mumbai University and a Chartered Accountancy Degree from the Institute of Chartered Accountants of India. He currently serves on the boards of Ranger Energy Services, Inc. and Allison Transmission Holdings. Mr. Guruswamy brings a unique combination of expertise in the energy, digital technology, and software industries, including experience as a global VP of software services for a leading global energy technology company. He is co-founder and General Partner at Lavni Ventures USA and India and a Venture Partner at CSL Capital Management, an investment firm. Mr. Guruswamy holds a Bachelor of Technology degree in Chemical Engineering from the Indian Institute of Technology, Madras and a Master of Science degree in Chemical Engineering from the Rensselaer Polytechnic Institute. Bekanntmachung • Mar 08
Stem, Inc. Announces Management Changes Effective March 6, 2025, Michael Carlson, formerly the Stem, Inc.’s Chief Operating Officer, has changed roles and assumed the position of President, Managed Services. Reported Earnings • Mar 06
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: US$5.29 loss per share (further deteriorated from US$0.90 loss in FY 2023). Revenue: US$144.6m (down 69% from FY 2023). Net loss: US$854.0m (loss widened US$713.6m from FY 2023). Revenue exceeded analyst estimates by 6.1%. Earnings per share (EPS) missed analyst estimates by 4.0%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 29 percentage points per year, which is a significant difference in performance. Bekanntmachung • Feb 19
Stem, Inc. to Report Q4, 2024 Results on Mar 04, 2025 Stem, Inc. announced that they will report Q4, 2024 results at 4:05 PM, US Eastern Standard Time on Mar 04, 2025 Price Target Changed • Feb 14
Price target decreased by 43% to US$1.07 Down from US$1.88, the current price target is an average from 11 analysts. New target price is 110% above last closing price of US$0.51. Stock is down 84% over the past year. The company is forecast to post a net loss per share of US$5.09 next year compared to a net loss per share of US$0.90 last year. Major Estimate Revision • Nov 10
Consensus revenue estimates fall by 27% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$185.2m to US$135.8m. Forecast losses increased from -US$5.02 to -US$5.17 per share. Electrical industry in the US expected to see average net income growth of 23% next year. Consensus price target of US$1.91 unchanged from last update. Share price fell 9.4% to US$0.36 over the past week. Major Estimate Revision • Nov 07
Consensus revenue estimates fall by 39% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$222.6m to US$135.3m. Forecast losses increased from -US$4.39 to -US$5.16 per share. Electrical industry in the US expected to see average net income growth of 21% next year. Consensus price target broadly unchanged at US$2.07. Share price fell 7.3% to US$0.35 over the past week. Buy Or Sell Opportunity • Nov 05
Now 27% overvalued Over the last 90 days, the stock has fallen 24% to US$0.45. The fair value is estimated to be US$0.35, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last 3 years. Earnings per share has declined by 65%. For the next 3 years, revenue is forecast to grow by 32% per annum. Earnings are also forecast to grow by 87% per annum over the same time period. Bekanntmachung • Nov 02
Stem, Inc. Updates Earnings Guidance for the Full Year 2024 Stem, Inc. updated earnings guidance for the full year 2024. For the year, the company now expects revenue in the range of $135 million - $155 million against previous guidance range of $200 million - $270 million. Reported Earnings • Nov 01
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: US$0.91 loss per share (further deteriorated from US$0.49 loss in 3Q 2023). Revenue: US$29.3m (down 78% from 3Q 2023). Net loss: US$148.3m (loss widened 92% from 3Q 2023). Revenue missed analyst estimates by 47%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Electrical industry in the US. Bekanntmachung • Oct 24
Stem, Inc. Appoints Albert Hofeldt as Chief Technology Officer Stem Inc. announced Albert Hofeldt, PhD as company's Chief Technology Officer (CTO), reporting to interim Chief Executive Officer (CEO), David Buzby, effective immediately. In his prior role as the Company's Executive Vice President (EVP) of Technology, Dr. Hofeldt has successfully led the critical responsibilities of advancing the Company's technology innovation since 2022 and will further advance Stem's delivery of AI-enabled software solutions for the clean energy market as Stem's CTO. His success with cloud platform architecture and tech transformations inclusive of AI and machine learning (ML), energy markets and trading, IoT and multi-cloud builds will be critical in executing a key pillar of Stem's refreshed software strategy to accelerate the delivery of advanced software solutions and services that help drive the company's growth and profitability. Dr. Hofeldt will lead Stem's efforts to deliver enhanced AI-enabled software and edge device capabilities as part of the company's recently announced software and services-centric strategy. His primary focus will be to combine Stem's award-winning, hardware-agnostic PowerTrack and Athena platforms into a single platform that spans asset management and optimization software across both solar and storage assets, and other technologies over time. Albert joined Stem two years ago as Senior Vice President (SVP) of Technology, and helped integrate Stem's solar and storage technology teams, extended the Company's software development expertise through key hires, and expanded Stem's Technology Center of Excellence in India. In addition, Albert has led the development of Stem's next generation software solutions including Athena, the Company's AI-driven clean energy software platform, PowerTrack Asset Performance Management (APM), PowerBidder Pro, and the overall enhanced user experience of Stem's software solutions. Prior to joining Stem, Albert served as CTO of LiquidX, where he launched a new multi-asset class cloud-based trading and blockchain digitization platform. He was also CTO at Genscape, a leading energy market intelligence company, where he led the 'platformization' initiative with the launch of their cloud-based multi-asset class energy and IoT ingestion platform. Albert also held SVP technology positions at Thomson Reuters/Trading and 10 years of tech consulting experience at Deloitte and Accenture. Albert earned his PhD in Engineering from Oxford University. Price Target Changed • Oct 17
Price target decreased by 9.3% to US$2.18 Down from US$2.40, the current price target is an average from 13 analysts. New target price is 279% above last closing price of US$0.57. Stock is down 84% over the past year. The company is forecast to post a net loss per share of US$4.40 next year compared to a net loss per share of US$0.90 last year. Buy Or Sell Opportunity • Oct 03
Now 40% overvalued Over the last 90 days, the stock has fallen 58% to US$0.48. The fair value is estimated to be US$0.34, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 47% over the last 3 years. Earnings per share has grown by 8.0%. For the next 3 years, revenue is forecast to grow by 28% per annum. Earnings are also forecast to grow by 86% per annum over the same time period. Bekanntmachung • Oct 01
Stem, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Stem, Inc. announced that they will report Q3, 2024 results at 4:05 PM, US Eastern Standard Time on Oct 30, 2024 Bekanntmachung • Sep 17
Stem, Inc. Announces Chief Executive Officer Changes Stem, Inc. announced that John Carrington has stepped down as Chief Executive Officer (CEO), effective immediately. To ensure a smooth transition, Mr. Carrington will serve in an advisory capacity through December 31, 2024. Stem’s Board, with assistance of an executive search firm, is conducting a search, which will include internal and external candidates, to identify a permanent CEO to lead Stem’s evolution as a leading energy software, technology, and services company. David Buzby, Executive Chair of the Company’s Board of Directors, has been appointed interim CEO, effective immediately. Mr. Buzby will continue to serve in his current role as Executive Chair of the Board of Directors. The Company is concluding its previously announced strategy review and expects to publicly announce the outcome of its review in the coming weeks. The identification of a new permanent CEO is critical to the Company’s successful execution of its new strategy. David Buzby has been starting, building and investing in “impact” businesses for the last 33 years with an emphasis on renewable energy generation, energy storage/grid services, decarbonizing the built environment, recycling, carbon removal and lithium production. He currently also sits on the Board of privately held Wondrwall Holdco Ltd. and Spring Valley Acquisition Corp. II. Previously, he was an early investor in, and a board member of, Sunrun Inc.; a founding investor, Chairman and Chief Executive Officer, of SunEdison, LLC before its sale to MEMC Electronic Materials, Inc.; and a founding investor, board member and chair of the audit committee of ValueClick before its sale to Alliance Data Systems Corporation; as well as an investor and board member of many private companies. He has also held senior executive roles in numerous companies, including Chairman, Chief Executive Officer, Chief Operating Officer and Chief Financial Officer. Mr. Buzby received his M.B.A. from Harvard Business School in 1988 and a B.A. from Middlebury College in 1982. Bekanntmachung • Sep 16
Stem, Inc. Announces Stepped Down of John Carrington as Member of the Board of Directors Stem, Inc. announced that John Carrington has stepped down as a member of the Board of Directors, effective immediately. To ensure a smooth transition, Mr. Carrington will serve in an advisory capacity through December 31, 2024. Buy Or Sell Opportunity • Sep 11
Now 34% overvalued Over the last 90 days, the stock has fallen 61% to US$0.46. The fair value is estimated to be US$0.34, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 47% over the last 3 years. Earnings per share has grown by 8.0%. For the next 3 years, revenue is forecast to grow by 28% per annum. Earnings are also forecast to grow by 86% per annum over the same time period. Bekanntmachung • Sep 01
Stem Receives Continued Listing Standard Notice from NYSE Stem, Inc. announced that, on August 28, 2024, it had received a written notice from the New York Stock Exchange (the “NYSE”) that the average closing price of its shares of common stock had fallen below $1.00 per share over a period of 30 consecutive trading days, which is the minimum average closing price required to maintain continued listing on the NYSE. Stem will respond to the NYSE within 10 business days of receipt of the notice regarding its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. Under the NYSE's rules, the cure period extends for six months following receipt of the notice. The Company's shares of common stock continue to trade on the NYSE, subject to compliance with other continued listing requirements. Under the NYSE’s rules, Stem can regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period, its common stock has a closing share price of at least $1.00 per share and an average closing price of at least $1.00 per share over the 30-trading-day period ending on the last trading day of such month. Failure to satisfy the conditions of the cure period or to maintain other listing requirements could lead to a delisting. The NYSE’s notice does not affect Stem’s business operations or its reporting obligations with the SEC, and does not conflict with or cause an event of default under any of Stem’s material debt or other agreements. Major Estimate Revision • Aug 18
Consensus revenue estimates decrease by 19% The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from US$347.3m to US$282.9m. EPS estimate unchanged at -US$4.40 per share. Electrical industry in the US expected to see average net income growth of 19% next year. Consensus price target of US$2.44 unchanged from last update. Share price fell 2.7% to US$0.56 over the past week. Major Estimate Revision • Aug 14
Consensus revenue estimates fall by 47% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$599.7m to US$315.9m. Forecast losses increased from -US$0.892 to -US$4.40 per share. Electrical industry in the US expected to see average net income growth of 17% next year. Consensus price target down from US$3.49 to US$2.44. Share price fell 47% to US$0.53 over the past week. Bekanntmachung • Aug 09
Stem, Inc. Updates Revenue Guidance for the Third Quarter and Fourth Quarter of 2024 Stem, Inc. updated revenue guidance for the third quarter and fourth quarter of 2024. For the third quarter, the company expects revenue to be in the range of $30 million to $50 million.
For the fourth quarter, the company expects revenue to be in the range of $110 million to $160 million. New Risk • Aug 08
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$96.0m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Negative equity (-US$203m). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$59m net loss in 2 years). Shareholders have been diluted in the past year (4.4% increase in shares outstanding). Market cap is less than US$100m (US$96.0m market cap). Price Target Changed • Aug 08
Price target decreased by 22% to US$2.71 Down from US$3.49, the current price target is an average from 12 analysts. New target price is 393% above last closing price of US$0.55. Stock is down 91% over the past year. The company is forecast to post a net loss per share of US$4.42 next year compared to a net loss per share of US$0.90 last year. Reported Earnings • Aug 07
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: US$3.59 loss per share (down from US$0.12 profit in 2Q 2023). Revenue: US$34.0m (down 63% from 2Q 2023). Net loss: US$582.3m (down US$601.4m from profit in 2Q 2023). Revenue missed analyst estimates by 47%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Electrical industry in the US. Bekanntmachung • Jul 25
Stem, Inc. to Report Q2, 2024 Results on Aug 06, 2024 Stem, Inc. announced that they will report Q2, 2024 results at 4:05 PM, US Eastern Standard Time on Aug 06, 2024 Recent Insider Transactions Derivative • May 19
Chief Revenue Officer notifies of intention to sell stock Alan Russo intends to sell 73k shares in the next 90 days after lodging an Intent To Sell Form on the 16th of May. If the sale is conducted around the recent share price of US$1.32, it would amount to US$97k. Since September 2023, Alan's direct individual holding has increased from 139.59k shares to 212.91k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months. Major Estimate Revision • May 10
Consensus EPS estimates fall by 32% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$652.3m to US$616.6m. Losses expected to increase from US$0.65 per share to US$0.86. Electrical industry in the US expected to see average net income growth of 12% next year. Consensus price target down from US$4.78 to US$3.83. Share price fell 12% to US$1.20 over the past week. Recent Insider Transactions • May 08
CEO & Director recently sold US$359k worth of stock On the 2nd of May, John Carrington sold around 194k shares on-market at roughly US$1.85 per share. This transaction amounted to 28% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. John has been a net seller over the last 12 months, reducing personal holdings by US$570k. Price Target Changed • May 05
Price target decreased by 16% to US$4.02 Down from US$4.78, the current price target is an average from 13 analysts. New target price is 196% above last closing price of US$1.36. Stock is down 69% over the past year. The company is forecast to post a net loss per share of US$0.91 next year compared to a net loss per share of US$0.90 last year.